*To The Editor*,

The current COVID-19 pandemic is causing severe damage to the mankind through direct impact on health and also collaterally affecting all aspects of life including the mental health. The impending mental health crisis has attracted the attention of global experts and organisations necessitating the documentation of impact of COVID-19 on mental health especially among the vulnerable populations ([@bib0055]). Pregnancy and the postpartum period are known to have increased vulnerability to psychiatric disorders ([@bib0025]). Earlier studies reported the association of other coronaviruses with a range of psychiatric disorders ([@bib0020]; [@bib0045]). However, there is no information on new-onset psychosis in asymptomatic patients or post-partum women with COVID-19. We report three cases of post-partum psychosis (PP) associated with asymptomatic COVID-19 managed at Topiwala National Medical College (TNMC) & B. Y. L. Nair Charitable Hospital (NH). NH is a an academic tertiary care public hospital and a dedicated COVID-19 hospital in Mumbai, India, receiving referrals from all over the Mumbai Metropolitan Region (MMR)([@bib0030]). In the initial phase of three months of COVID-19 pandemic (from 4th April 2020 to 31st July 2020), NH treated three asymptomatic, RT-PCR confirmed COVID-19 women with PP. The demographic, clinical characteristics, delivery details and management of COVID-19 mothers with PP are described in [Table 1](#tbl0005){ref-type="table"} . This study was approved by Institutional Ethics Committees of TNMC, Mumbai and ICMR-National Institute for Research in Reproductive Health, Mumbai.Table 1Characteristics, Symptoms and Treatment of Postpartum Psychosis Patients with SARS-CoV-2 Infection.Table 1Sr. No.PPP1PPP2PPP3Age in years242323Socio-economic StatusLowLowLowReligionHinduHinduMuslimGravida (G)/Parity (P)G2P1G1G1Contact with Positive PersonNoNoNoForeign TravelNoNoNoIndication for COVID-19 RT-PCR testingUniversal testingUniversal testingUniversal testingWeeks of Gestation (+ represents days)38 + 139 + 139 + 2Previous Caesarean SectionYesNoNoSpontaneous Conception/ IVFSpontaneousSpontaneousSpontaneousAntenatal comorbiditiesGestational HTNNoNoPast personal history of Psychiatric IllnessNoNoNoFamily history of Psychiatric illnessNoNoNoHistory of substance useNoNoNoDepression, Anxiety, or PTSDNoNoNoPsychosis SymptomsDOP, DOR, agitated behaviour SHB (suspiciousness that people are trying to harm her), AH (various unknown voices), reduced sleep and loss of appetite, severe fearfulness (drank two sips of methylated spirit in an attempt commit suicide)DOP (suspicious of doctors and nurses around her that they were trying to make her and her child COVID-19 positive), aggressive behaviour towards hospital staff, belief that she was COVID-19 negative. Belief of doctors informing all other patients to stay away from her, Believed that people are keeping an eye on her, believed her conversations are being traced, loss of appetite as she felt she was being poisonedIOR, guilt (people are blaming her for COVID-19), IOP and harm to baby, abusive behaviour without any provocation, had put talcum powder in the mouth and eyes of her baby. Fearful that she being scanned and passing this information to doctors. She felt that other people are discussing about her and blaming her COVID-19 spreader.Duration of Symptoms7 days3 days7 daysTreatmentRestrained, interaction of mother and baby restricted, Inj. Haloperidol 10 mg + Inj. Promethazine 50 mg\
T. haloperidol 15mg\
T. Trihexyphenidyl 2 mg increased to 6mgclose supervision and supervised breastfeeding, T. Haloperidol 5 mg bd\
T. Trihexyphenidyl 2 mg\
T. Lorazepam 2 mg ½ hsinteraction of mother and baby restricted, T. Olanzapine 10 mgChest X-ray changesNoNoNoOxygen RequirementNoNoNoICU admissionNoNoNoMortalityNoNoNo[^2]

All three women had uneventful deliveries (two caesarean deliveries and one normal vaginal delivery) and gave birth to healthy new-borns (Table S1). They developed PP within seven days of giving birth (mean 5 days). Their other laboratory investigations, neurological work-up and general examination was normal. Diagnosis of PP was based on the presence of psychotic symptoms in the absence of other organic or mood disorders. All women recovered within seven days of treatment and were discharged. Duration of symptoms lasted till seven days in two patients and three days in one patient. Two patients received haloperidol, trihexyphenidyl and third patient was given olanzapine ([Table 1](#tbl0005){ref-type="table"}).

Post-partum mothers are vulnerable to a number of psychiatric disorders, owing to physiological and psychological changes happening in the mother's body ([@bib0010]) Our patients had only psychogenic type of PP, as affective symptoms were characteristically absent in all three cases. However, prospective studies are required to generate robust data on association of PP with COVID-19. Affective symptoms have been shown to occur in majority of the cases and many cases present with rapid mood fluctuations ([@bib0010]). Onset of illness in all the three cases were in the first week following delivery. The most common symptoms in our cases were delusion of persecution and reference, which have been shown to be the most common in other studies as well ([@bib0035]; [@bib0050]). Two women in our series, had delusion surrounding the SARS-CoV-2 infection, which goes in favor of psychogenic rather than a structural cause. This could be due to added stress surrounding COVID-19, as stress is known to be one of the main factors in development of PP. Aggression has also been noted in PP and was present in all of the cases. Around 35% of the women with PP pose a risk to their infant ([@bib0050]) . Two women required separation of infant from mother and one required supervision. A sense of well-being and hypomanic symptoms have frequently been shown to occur in prodrome of PP([@bib0050]), however none were seen in our series. Established risk factors that were evident in our sample were parity (two primipara), CS (two) and gestational hypertension (one). First pregnancies and preeclampsia are greater psychosocial stressor. It has also been hypothesized that biological factors could be in play ([@bib0005]) Neuropsychiatric manifestations like depression, anxiety and psychosis of COVID-19 infection are accounted to a hypercoagulable state ([@bib0060]). Infection or treatment with steroids was not present in our patients, ruling them out, as the cause ([@bib0065]) . Delirium was ruled out in all of our cases.

An important stressor is social isolation. Usually, new mothers are supported by their families during the stressful puerperium in India. Social isolation in SARS-CoV-2 causing psychosis has been documented([@bib0015]). Women with first episode of PP have demonstrated elevations in IL-6, thereby supporting the immune mediated mechanism in PP ([@bib0040]). A profound inflammatory response to SARS-CoV-2 infection, known as 'cytokine storm' has been described and has been hypothesized to play a role in neuropsychiatric complications ([@bib0060]). Raised antibody titers against HCoV was observed in recent psychotic episode ([@bib0045]). Although, we cannot directly explain the role of SARS-CoV-2 in PP, we can propose possible mechanisms based on the available information in the literature. It might be possible that altered immune mechanisms in patients with SARS-CoV-2 infection may be a risk factor for developing psychiatric illness. Neuropsychiatric sequalae can also be due to a direct neurotoxic effect of the virus or the host's immune response towards it. Having comorbid COVID-19 infection or the fact that these women had to deliver during the COVID-19 pandemic can itself put undue stress on them, leading to precipitation of psychiatric illnesses, such as PP.
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